Investigational Drugs with Clinical Trials for: Triple Negative Breast Neoplasms
✉ Email this page to a colleague
Drugname | Indication |
---|---|
AB928 | Triple Negative Breast Neoplasms |
Rintatolimod | Triple Negative Breast Neoplasms |
Navitoclax | Triple Negative Breast Neoplasms |
>Drugname | >Indication |